
Envision Pharma acquires two medical education specialists in takeover deal
pharmafile | September 11, 2015 | Appointment | Medical Communications |
Two principals from Alligent Biopharm Consulting have joined the UK communications group Envision Pharma following an acquisition deal.
Alligent’s two principals, Joe Kohles and David Thompson, will join the Envision Pharma leadership team.
Kohles and Thompson say: “We are delighted to join the Envision Pharma Group. Our focus on medical strategy, coupled with Envision’s global presence and technology leadership position, offers the potential for us to expand and enrich our service breadth and offering to current and future clients alike. We look forward to joining the Group’s leadership team and contributing to the continued success of both Alligent and Envision.”
Envision’s chief executive Brian Hepburn comments: “The addition of Alligent to the Envision Pharma Group further cements our core tenet of becoming the leading international medical affairs agency. By acquiring Alligent, we are able to expand the capabilities we offer to medical affairs teams to ensure optimal evidence communication and ultimate product adoption based on scientific rigour.”






